Inhibiting inflammatory cytokines

Seminars in Nephrology

Volumn 16, Issue 6, 1996, Pages 576-582

  Kluth, David C ^a   Rees, Andrew J ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE GLOMERULONEPHRITIS; ALLERGIC ENCEPHALITIS; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNITY; CELL INFILTRATION; DRUG THERAPY; GLOMERULOPATHY; HUMAN; IMMUNE COMPLEX NEPHRITIS; INFLAMMATION; NONHUMAN; PASSIVE IMMUNIZATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CULTURE TECHNIQUES; CYTOKINES; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; INFLAMMATION; INTERLEUKINS; KIDNEY GLOMERULUS; MICE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029990795     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Savill J, Rees AJ. Mechanisms of glomerular inflammation, in Davidson AM, Cameron JS, Grunfeld J-P, Kerr DNS, Ritz E (eds): Oxford Textbook of Clinical Nephrology, 2nd ed. Oxford, Oxford University Press, 1996
2. Cattell V. Macrophages in acute glomerular inflammation. Kidney Int 45:945-952, 1994
3. Nikolic-Paterson DJ, Lan HY, Hill PA, et al. Macrophages in renal injury. Kidney Int 45:S79-S82, 1994 (suppl 45)
4. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 12:1314-1325, 1994
5. Tracy KJ, Cerami A. Tumour necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491-501, 1994
6. Riches D. Signalling heterogeneity as a contributing factor in macrophage functional diversity. Semin Cell Biol 6:377-384, 1995
7. Colotta F, Re F, Muzio M, Bertini R, et al. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4. Science 261:472-475, 1993
8. Abbott F, Tarn FWK, Ryan JJ, et al. Human mesangial cells synthesise interleukin-1a but not interluekin 1b, interleukin receptor antagonist or tumour necrosis factor. Nephrol Dial Transplantation 7:997-1001, 1992
9. Grell MD, Douni E, Wajant H, et al. The transmembrane form of tumour necrosis factor is the prime activating ligand of the 80 kDa TNF receptor. Cell 83:793-802, 1995
10. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily and cellular and viral proteins: Activation costimulation and death. Cell 76:959-962, 1994
11. Bazzoni F, Beutler B. The tumour necrosis ligand and receptor families. N Engl J Med 334:1717-1725, 1996
12. Matsumoto K. Production of interleukin-1 in glomerular cell cultures from rats with nephrotoxic serum nephritis. Clin Exp Immunol 75:123-128, 1989
13. Karkar AM, Koshino Y, Cashman SJ, et al: Passive immunisation against tumour necrosis factor-alpha (TNF-α) and IL- 1β protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol 90:312-318, 1992
14. Matsumoto K, Dowling J, Atkins RC. Production of interleukin-1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am J Nephrol 8:463-470, 1988
15. Ozen S, Saatci U, Tinaztepe K, et al. Urinary tumour necrosis factor levels in primary glomerulopathies. Nephron 66:291-294, 1994
16. Tomosugi N, Cashman S, Hay H, et al: Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumour necrosis factor, and IL-1. J Immunol 142:3083-3090, 1989
17. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652, 1991
18. Del Giudice G, Crow MK. Role of transforming growth factor beta (TGFβ) in systemic autoimmunity. Lupus 2:213-220, 1993
19. Gutterman JU: Cytokine therapeutics: Lessons from interferon alpha. Proc Natl Acad Sci 91:1198-1205, 1994
20. Schindler R, Clark BD, Dinarello CA. Dissociation between interleukin-1β mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem 265:10232-10237, 1990
21. Tilg H, Trehu E, Atkins MB, Dinarello CA, et al. Interleukin-6 (IL-6) as an anti-flammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble tumour necrosis factor receptor p55. Blood 83:113-118, 1994
22. Bogdan C, Nathan C. Modulation of macrophage functions by transforming growth factor b, interleukin-4 and interleukin-10. Proc NY Acad Sci USA 685:713-739, 1993
23. Suematsu S, Matsuda T, Aozasa K, et al: IgGI plasmacytosis in interleukin-6 transgenic mice. Proc Natl Acad Sci USA 86:7547-7550, 1989
24. 1 mice. J Clin Invest 94:585-591, 1994
25. Horii Y, Muraguchi A, Iwano M, et al. Involvement of IL-6 in mesangial proliferative glomemlonephritis. J Immunol 143:3949-3955, 1989
26. Reuf C, Budde K, Lacy J, et al. Interleukin-6 is an autocrine growth factor for mesangial cells. Kidney Int 38:249-257, 1991
27. Zoja C, Benigni A, Piccinini G, et al. Interleukin-6 stimulates gene expression of matrix components in bovine mesangial cells in culture. Mediators Infiamm 2:429-433, 1993
28. Floege J, Topley N, Hoppe J, et al. mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: Modulation and/or suppression by inflammatory cytokines. Clin Exp Immunol 86:334-341, 1991
29. Ikeda M, Ikeda U, Ohara T, et al. Recombinant interleukin-6 inhibits the growth of rat mesangial cells in culture. Am J Pathol 141:327-334, 1992
30. Abbott F, Ryan JJ, Ceska M, et al: Interleukin-1 beta stimulates human mesangial cells to synthesise and release interleukins-6 and -8. Kidney Int 40:597-605, 1991
31. Waldherr R, Noronha IL, Neimir Z, et al. Expression of cytokines and growth factors in human glomerulonephritis. Pediatr Nephrol 7:471-478, 1993
32. Ito Y, Fukatsu A, Baba M, et al: Pathogenic significance of interleukin-6 in a patient with antiglomerular basement membrane antibody-induced glomerulonephritis with multinucleated giant cells. Am J Kidney Dis 26:72-79, 1995
33. Chen WP, Lin CY. Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy. Nephron 68:10-19, 1994
34. Horn Y, Iwano M, Hirata E, et al. Role of interleukin-6 in the progression of mesangial proliferative glomerulonephritis. Kidney Int 43:71-75, 1993 (suppl 39)
35. Malide D, Russo P, Bendayan M: Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol 26:558-564, 1995
36. Fattori E, Della Rocca C, Costa P, et al. Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 83:2570-2579, 1994
37. Shen MM, Skoda RC, Cardiff RD, et al. Expression of LIF transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J 13:1375-1385, 1994
38. Ryffel B, Car BD, Gunn H, et al. Interleukin-6 exacerbates glomerulonephritis in (NZB × NZW) Fl mice. Am J Pathol 144:927-937, 1994
39. Floege J, Eng E, Young B A, et al. Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962,1993
40. Karkar AM, Tarn FW, Proudfoot AE, et al. Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. Kidney Int 44:967-973, 1993
41. Karkar AM, Smith J, Tarn FWK, et al. Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6. J Am Soc Nephrol 6:834, 1995
42. Mossman TRS, Sad S. The expanding universe of the T cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996
43. Zurawski G, de Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B-cells, but not on T-cells. Immunol Today 15:19-26, 1994
44. Colotta F, Re F, Muzio M, et al. Interleukin-13 (IL-13) induces expression and release of the interleukin-1 (IL-1) decoy receptor in human polymorphonuclear cells. J Biol Chem 269:12403-12406, 1994
45. Te Velde A, Huijbens RJF, De Vries JE, et al. IL-4 decreases FcgR membrane expression and FcgR-mediated cytotoxic activity of human monocytes. J Immunol 144:3046-3051, 1990
46. Okada H, Konishi K, Nakazato Y, et al. Interleukin-4 expression in mesangial proliferative glomerulonephritis. Am J Kidney Dis 23:242-6, 1994
47. Lakkis FG, Cruet EN. Cloning of rat interleukin-13 (IL-13) cDNA and analysis of IL-13 gene expression experimental glomerulonephritis. Biochem Biophys Res Commun 197:612-618, 1993
48. Lakkis FG, Baddoura FK, Cruet EN, et al. Anti-inflammatory lymphokine mRNA expression in antibody-induced glomerulonephritis. Kidney Int 49:117-126, 1996
49. Liblau RS, Singer SM, McDevitt HO. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38, 1995
50. Chen Y, Kuchroo VK, Inobe J-I, et al. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 265:1237-1240, 1994
51. Tarn FWK, Smith J, Karkar AM, et al. Interleukin (IL-4) upregulates decoy receptor for IL-1 and ameliorates nephrotoxic nephritis. J Am Soc Nephrol 6:1767, 1995
52. Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 56:1-26, 1994
53. Fouqueray B, Boutard V, Phillipe C, et al. Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Am J Pathol 147:176-182, 1995
54. Joyce DA, Gibbons DP, Green P, et al. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interIeukin-4, have contrasting effects on the release of soluble p75 tumour necrosis factor receptor by cultured monocytes. Eur J Immunol 24:2699-2705, 1994
55. Gerard C, Bruyns C, Marchant A, et al. Interleukin10 reduces the release of tumour necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547-550, 1993
56. Howard M, Muchamuel T, Andrade S, et al. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177:1205-1208, 1993
57. Marchant A, Bruyns C, Vandenabeele P, et al. IL-10 controls IFN- and TNF production during experimental endotoxemia. Eur J Immunol 24:1167, 1994
58. Ishida H, Muchamuel T, Sakaguchi S, et al. Continuous administration of anti-interleukin-10 antibodies delays onset of autoimmunity in NZBAV F1 mice. J Exp Med 179:305-310, 1994
59. Jacob CO, McDevitt HO. Tumour necrosis factor-α in murine autoimmune 'lupus' nephritis. Nature 331:256-258, 1988
60. Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 62:60-65, 1992